| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | 0.11 | 0.004 |
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | -0.1 | 0.004 |
| mRNA | KPT185 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.005 |
| mRNA | MLN4924 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.005 |
| mRNA | AUY922 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.005 |
| mRNA | tacedinaline | CTRPv2 | pan-cancer | AAC | -0.12 | 0.005 |
| mRNA | BRD-K34222889 | CTRPv2 | pan-cancer | AAC | -0.098 | 0.005 |
| mRNA | oligomycin a | CTRPv2 | pan-cancer | AAC | -0.11 | 0.005 |
| mRNA | narciclasine | CTRPv2 | pan-cancer | AAC | -0.1 | 0.006 |
| mRNA | BMS-708163 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.006 |